UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Explore which option—Dividend ETF Or Mutual Fund—delivers greater tax efficiency, with a quick look at how distributions and turnover impact taxes.
28,124 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Investors chase the next big energy winner as AI drives data centers demand. Oklo presents a high-risk, high-puture o...
Salesforce and Palantir posted strong quarters, but the market rewards or punishes them based on cash-return potentia...
Nvidia's latest earnings moment features a clear signal from Jensen Huang about AI demand and strategic momentum. Thi...
Realtor.com launches AGOYU AI-powered moving quotes, letting users generate real-time estimates from video without in...
M&A chatter centers on mid-cap SaaS names ASAN, FRSH, and PD as buyers hunt for platform fit and durable ARR. Here’s ...
The AI boom is reshaping how businesses buy computing power. This article breaks down two rising cloud players, why t...
A new global study links warming to a sharp rise in extreme heat stress affecting about one billion more people. The ...
Goldfinch outlines a phased wind-down of its Prime unit, shifting from growth to borrower recoveries and testing whet...
Domino's stock trades at a modest multiple, with a business built on digital ordering and value pricing. This guide e...
ASML, Europe’s largest semiconductor equipment maker, is poised to report second-quarter results as AI-driven demand ...
A fast-growing company with a software-led model and global expansion is catching investor attention. This growth sto...